Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check4 days agoChange DetectedNew entries were added to the record history: 'Study Status' on 2026-02-13 and a value '43' on 2026-02-12, with a deletion recorded on 2025-12-17.SummaryDifference0.2%

- Check11 days agoChange DetectedThe record history now includes a new revision entry: v3.4.2. The previous revision v3.4.1 has been removed from the listing.SummaryDifference0.1%

- Check19 days agoChange DetectedThe history shows a new revision entry (v3.4.1) and removal of the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no substantive changes to page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedThe record status changed to Active, not recruiting and IPDSharing was added. Updates were made to Contacts/Locations, Eligibility, Arms and Interventions, Conditions, Study Description, and Study Status.SummaryDifference1.0%

- Check91 days agoChange DetectedA new site revision entry v3.3.2 was added to the record history, and the older v3.2.0 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.